Sylvester Sanfilippo

Sylvester Sanfilippo earned his undergraduate degree from the University of Rochester in 1947. He then moved to the University of Utah in Salt Lake City for postgraduate studies, obtaining a Master of Science degree in Biochemistry in 1951 and a Doctor of Medicine degree in 1955 from the University of Utah School of Medicine. Following medical school, he completed pediatrics training at the University of Minnesota, interrupted by two years of service as a lieutenant pediatrician in the United States Navy Medical Corps in Portsmouth and Norfolk, Virginia. In 1960, Sanfilippo was awarded a postdoctoral research fellowship at the University of Minnesota, where he initiated a comprehensive study of children exhibiting symptoms of mucopolysaccharide storage disease. This research combined precise chemical measurements and identification of urinary acid mucopolysaccharides with detailed clinical evaluations. His investigations revealed eight mentally challenged children who excreted only heparitin sulfate in their urine, distinguishing this group from those with Hunter-Hurler syndrome, who also excreted chondroitin sulfate B. These patients displayed milder somatic and radiographic manifestations, prominent central nervous system involvement, coarse facial features, and mild skeletal abnormalities, indicating a novel inborn error of mucopolysaccharide metabolism.

In May 1963, Sanfilippo presented his groundbreaking findings at the American Pediatric Society meeting, followed by publication later that year in Pediatrics titled 'Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type)' co-authored with Robert Podosin, Leonard Langer, and Robert A. Good. This work established Sanfilippo syndrome, or mucopolysaccharidosis type III, as a distinct lysosomal storage disorder, earning international recognition and naming the condition after him. He continued research at the University of Minnesota for several years while entering private pediatric practice in Richfield, Minnesota, in April 1962, serving patients for 26 years until his retirement in June 1988. Sanfilippo also engaged in regional health care planning and published a perinatal mortality review study in 1976. His discovery has profoundly influenced pediatric genetics, advancing understanding and research into heparan sulfate metabolism defects, with ongoing implications for diagnosis and treatment of this rare disorder.